187 related articles for article (PubMed ID: 21810053)
1. Immunomodulatory therapy for severe influenza.
Darwish I; Mubareka S; Liles WC
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):807-22. PubMed ID: 21810053
[TBL] [Abstract][Full Text] [Related]
2. The cytokine storm of severe influenza and development of immunomodulatory therapy.
Liu Q; Zhou YH; Yang ZQ
Cell Mol Immunol; 2016 Jan; 13(1):3-10. PubMed ID: 26189369
[TBL] [Abstract][Full Text] [Related]
3. Treating influenza with statins and other immunomodulatory agents.
Fedson DS
Antiviral Res; 2013 Sep; 99(3):417-35. PubMed ID: 23831494
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive therapies and immunomodulatory agents in the management of severe influenza.
Hui DS; Lee N; Chan PK
Antiviral Res; 2013 Jun; 98(3):410-6. PubMed ID: 23578727
[TBL] [Abstract][Full Text] [Related]
5. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
[TBL] [Abstract][Full Text] [Related]
6. [Cytokine storm in avian influenza].
Us D
Mikrobiyol Bul; 2008 Apr; 42(2):365-80. PubMed ID: 18697437
[TBL] [Abstract][Full Text] [Related]
7. The role of adjuvant immunomodulatory agents for treatment of severe influenza.
Hui DS; Lee N; Chan PK; Beigel JH
Antiviral Res; 2018 Feb; 150():202-216. PubMed ID: 29325970
[TBL] [Abstract][Full Text] [Related]
8. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza.
Mancini N; Solforosi L; Clementi N; De Marco D; Clementi M; Burioni R
Antiviral Res; 2011 Oct; 92(1):15-26. PubMed ID: 21798290
[TBL] [Abstract][Full Text] [Related]
9. Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.
Elbahesh H; Gerlach T; Saletti G; Rimmelzwaan GF
Front Immunol; 2019; 10():809. PubMed ID: 31031778
[TBL] [Abstract][Full Text] [Related]
10. Appropriate response to influenza A (H1N1) virus vaccination in patients with inflammatory bowel disease on maintenance immunomodulator and/or biological therapy.
Molnár T; Farkas K; Jankovics I; Melles M; Nagy F; Szepes Z; Wittmann T
Am J Gastroenterol; 2011 Feb; 106(2):370-2. PubMed ID: 21301464
[No Abstract] [Full Text] [Related]
11. High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection.
Liu L; Li R; Pan Y; Chen J; Li Y; Wu J; Zhu Y
Clin Chim Acta; 2011 May; 412(11-12):1081-5. PubMed ID: 21354125
[TBL] [Abstract][Full Text] [Related]
12. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.
Moseley CE; Webster RG; Aldridge JR
Influenza Other Respir Viruses; 2010 Sep; 4(5):307-11. PubMed ID: 20716159
[TBL] [Abstract][Full Text] [Related]
14. Interferon-β modulates type 1 immunity during influenza virus infection.
Yoo JK; Baker DP; Fish EN
Antiviral Res; 2010 Oct; 88(1):64-71. PubMed ID: 20659503
[TBL] [Abstract][Full Text] [Related]
15. Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
Eichelberger MC; Prince GA; Ottolini MG
Virology; 2004 May; 322(2):300-7. PubMed ID: 15110527
[TBL] [Abstract][Full Text] [Related]
16. Passive immune therapy and other immunomodulatory agents for the treatment of severe influenza: Systematic review and meta-analysis.
Lim VW; Tudor Car L; Leo YS; Chen MI; Young B
Influenza Other Respir Viruses; 2020 Mar; 14(2):226-236. PubMed ID: 31733048
[TBL] [Abstract][Full Text] [Related]
17. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection.
Lee SM; Cheung CY; Nicholls JM; Hui KP; Leung CY; Uiprasertkul M; Tipoe GL; Lau YL; Poon LL; Ip NY; Guan Y; Peiris JS
J Infect Dis; 2008 Aug; 198(4):525-35. PubMed ID: 18613795
[TBL] [Abstract][Full Text] [Related]
18. Pandemic influenza: a primer.
Swartz KA; Luby JP
Tex Med; 2007 Oct; 103(10):31-4. PubMed ID: 18078243
[TBL] [Abstract][Full Text] [Related]
19. Update on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS).
Advisory Committee On Immunization (NACI)
Can Commun Dis Rep; 2006 Mar; 32(ACS-2):1-3. PubMed ID: 16710946
[No Abstract] [Full Text] [Related]
20. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
